title: [Progress in clinical cardiology. The clinical cardiologist's response to new cardiovascular drugs].
abstract: This article contains a review of major new developments in drug treatment and the impact they could have for the general cardiologist. New treatments for arrhythmias, chronic ischemic heart disease, and secondary prevention are changing the practice of clinical cardiology. In addition, recent publications on treatment adherence and therapeutic inertia are discussed. Finally, the work of the Clinical Cardiology and Outpatient Section of the Spanish Society of Cardiology during the last year is described.
authors.affiliation: Servicio de Cardiología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
authors.forename: Xavier
authors.initials: X
authors.lastname: Borrás-Pérez
authors.forename: Nekane
authors.initials: N
authors.lastname: Murga-Eizagaechevarría
mesh_terms: D000553:Ambulatory Care; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D002309:Cardiology / Q000639:trends*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy; D055502:Secondary Prevention
chemical_list: D000889:Anti-Arrhythmia Agents; D002317:Cardiovascular Agents